Functional Outcome, Recanalization, and Hemorrhage Rates After Large Vessel Occlusion Stroke Treated With Tenecteplase Before Thrombectomy - Archive ouverte HAL Access content directly
Journal Articles Neurology Year : 2021

Functional Outcome, Recanalization, and Hemorrhage Rates After Large Vessel Occlusion Stroke Treated With Tenecteplase Before Thrombectomy

(1, 2) , (3) , (4, 5, 6) , (7) , (8) , (3) , (9) , (10, 4, 5, 6) , (10, 4, 5, 6) , (1) , (3) , (3) , (3) , (11) , (4, 5, 6) , (12) , (13) , (14) , (9) , (9) , (11) , (1) , (3)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Gaultier Marnat
Erwah Kalsoum
  • Function : Author
Igor Sibon

Abstract

Objective: To investigate in routine care the efficacy and safety of IV thrombolysis (IVT) with tenecteplase prior to mechanical thrombectomy (MT) in patients with large vessel occlusion acute ischemic strokes (LVO-AIS), either secondarily transferred after IVT or directly admitted to a comprehensive stroke center (CSC). Methods: We retrospectively analyzed clinical and procedural data of patients treated with 0.25 mg/kg tenecteplase within 270 minutes of LVO-AIS who underwent a brain angiography. The main outcome was 3-month functional independence (modified Rankin scale score ≤ 2). Recanalization (revised Treatment in Cerebral Ischemia score 2b-3), was evaluated before (pre-MT) and after MT (final). Results: We included 588 patients (median age 75 years [interquartile range (IQR) 61-84]; 315 women [54%]; median NIH Stroke Scale [NIHSS] score 16 [IQR 10-20]), of which 520 (88%) were secondarily transferred after IVT. Functional independence occurred in 47% (n = 269/570; 95%CI 43.0-51.4) of patients. Pre-MT recanalization occurred in 120 patients (20.4%; 95%CI 17.2-23.9), at a similar rate across treatment paradigms (direct admission, n = 14/68 [20.6%]; secondary transfer, n = 106/520 [20.4%]; p > .99) despite a shorter median IVT-to-puncture time in directly admitted patients (38 [IQR 23-55] vs 86 [IQR 70-110] minutes; p < .001). Final recanalization was achieved in 492 patients (83.7%; 95%CI 80.4-86.6). Symptomatic intracerebral hemorrhage occurred in 2.5% of patients (n = 14/567; 95%CI 1.4-4.1). Conclusions: Tenecteplase before MT is safe, effective and achieves a fast recanalization in everyday practice in patients secondarily transferred or directly admitted to a CSC, in line with published results. These findings should encourage its wider use in bridging therapy. Classification of evidence: This study provides class IV evidence that tenecteplase within 270 minutes of LVO-AIS is increases the probability of functional independence.
Fichier principal
Vignette du fichier
Gerschenfeld et al. Neurology. 2021.pdf (620.29 Ko) Télécharger le fichier

Dates and versions

inserm-03379553 , version 1 (15-10-2021)

Identifiers

Cite

Gaspard Gerschenfeld, Didier Smadja, Guillaume Turc, Stephane Olindo, François-Xavier Laborne, et al.. Functional Outcome, Recanalization, and Hemorrhage Rates After Large Vessel Occlusion Stroke Treated With Tenecteplase Before Thrombectomy. Neurology, 2021, pp.10.1212/WNL.0000000000012915. ⟨10.1212/WNL.0000000000012915⟩. ⟨inserm-03379553⟩
28 View
122 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More